000			03937nam a2200409 c 4500
710	2		_aSpringerLink (Online service) _9106996
999			_c112899 _d112899 _x1
001			112899
003			ES-MaUEC
005			20230102113549.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			180925s2019 gw a o |||| 0|eng d
020			_a9783319972657
024	7		_a10.1007/978-3-319-97265-7 _2doi
040			_bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC919 _b2019 EB
245	0	0	_aContemporary Pharmacotherapy of Overactive Bladder _cedited by Lindsey Cox, Eric S. Rovner
264		1	_aCham _bSpringer International Publishing : _bImprint: Springer _c2019.
300			_a1 recurso en línea (XV, 321 páginas 6 ilustraciones, 2 ilustraciones a color)
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	0		_aMedicine (Springer-11650)
505	0		_aPathophysiology of Overactive Bladder -- Diagnosis of Overactive Bladder. The Placebo Effect in Overactive Bladder Syndrome -- Outcome Measures and Patient Expectations for Overactive Bladder -- National and International Guidelines in Overactive Bladder -- β3-Agonists for Overactive Bladder -- Combination Pharmacotherapy for Overactive Bladder -- Behavioral Therapy in Combination with Pharmacotherapy -- Pharmacotherapy for Nocturia -- Intravesical Chemodenervation and Toxins -- Other Treatment for Overactive Bladder, Including Intravesical -- Future Considerations in Overactive Bladder Pharmacotherapy -- Considerations in Pediatric Overactive Bladder -- Considerations in Male Overactive Bladder -- Considerations in the Medically Complex and Frail Elderly -- Individualizing Drug Therapy.
520	3		_aThis text provides a comprehensive, state-of-the art review of pharmacotherapy for the overactive bladder, and serve as a valuable resource forclinicians, surgeons, and researchers with an interest in OAB. The early chapters will describe the pathophysiology of OAB, algorithm, and provide the readers with a practical guide for evaluating the OAB patient. The next section describes the unique challenges involved in the study of OAB and helps the reader navigate the complexities of the literature on the topic. All chapters are written by experts in their fields and include the most up-to-date scientific and clinical information. The text includes a review of the clinical guidelines for OAB, and a detailed description of the individual therapies, including antimuscarinics, Beta-3 agonists, (insert comma) and chemodenervation. Extensive tabulation of contemporary literature makes this a matchless resource that provides a detailed account of the current evidence for the use of each of these therapies. The text concludes with chapters on unique populations with OAB, and future directions in the research field. Contemporary Pharmacotherapy of Overactive Bladder unites a unique set of thought leaders in the field of voiding dysfunction to create a comprehensive resource that will be useful for a variety of clinicians who treat OAB, including urologists, urogynecologists, general gynecologists, family practitioners, and geriatricians.
988			_aSpringer_Medicine_2019
650		7	_aVejiga _9670136 _2embne _xEnfermedades _xTratamiento
700	1		_aCox, Lindsey. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aRovner, Eric S. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _994654
776	0	8	_iPrinted edition: _z9783319972640
776	0	8	_iPrinted edition: _z9783319972664
776	0	8	_iPrinted edition: _z9783030073282
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-97265-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_dz _feng _ggw _h0 _b07/2019 _eu _zSI